Zobrazeno 1 - 10
of 82
pro vyhledávání: '"A. Ambrosetti"'
Autor:
Christopher Montemagno, Jérôme Durivault, Cécile Gastaldi, Maeva Dufies, Valérie Vial, Xingkang He, Damien Ambrosetti, Anna Kamenskaya, Sylvie Negrier, Jean‐Christophe Bernhard, Delphine Borchiellini, Yihai Cao, Gilles Pagès
Publikováno v:
Molecular Oncology.
Autor:
Samantha Ferrari, L. Rigacci, Monia Capponi, Alessandro Pulsoni, Giuseppe Visani, Luca De Carolis, Pier Luigi Zinzani, Robin Foà, Paolo Falcucci, Enrico Tiacci, G. Gaidano, Eugenio Lucia, Agostino Antolino, Francesco Zaja, A. Ambrosetti, Stefano Ascani, Roberta Della Seta, Edoardo Simonetti, Natalia Frattarelli, Vincenzo Perriello, Brunangelo Falini
Publikováno v:
The New England journal of medicine. 384(19)
Hairy-cell leukemia (HCL) is a CD20+ indolent B-cell cancer in which a BRAF V600E kinase-activating mutation plays a pathogenetic role. In clinical trials involving patients with refractory or relapsed HCL, the targeting of BRAF V600E with the oral B
Autor:
Christopher Montemagno, Gilles Pagès, Renaud Grépin, Arnaud Borderie, Michael Coutts, Delphine Borchiellini, Damien Ambrosetti, Charlotte Paoli, Matthieu Durand, Jean-Christophe Bernhard, Nathalie Rioux-Leclercq, Olivia Rastoin, Maeva Dufies
Publikováno v:
BJU International
BJU International, 2022, 129 (1), pp.80-92. ⟨10.1111/bju.15506⟩
BJU International, Wiley, 2021, ⟨10.1111/bju.15506⟩
BJU International, 2022, 129 (1), pp.80-92. ⟨10.1111/bju.15506⟩
BJU International, Wiley, 2021, ⟨10.1111/bju.15506⟩
International audience; Objectives: To investigate the role of cancer-associated fibroblasts (CAFs) in clear cell renal cell carcinoma (ccRCC) with respect to tumour aggressiveness, metastasis development, and resistance to anti-angiogenic therapy (v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99a5b132ebf2bd7f4db2126fc13952f8
https://hal.science/hal-03476907/document
https://hal.science/hal-03476907/document
Autor:
Davide Ambrosetti, Giovanna Damia, Riccardo Bellazzi, Elena Tagliavini, Francesca Reggiani, Elisabetta Sauta, Valentina Sancisi, Eleonora Zanetti, Federica Torricelli, Alessia Ciarrocchi, Giulia Gobbi, Giacomo Santandrea
Publikováno v:
Molecular Cancer
Molecular Cancer, Vol 20, Iss 1, Pp 1-6 (2021)
Molecular Cancer, Vol 20, Iss 1, Pp 1-6 (2021)
No Abstract available.
Autor:
Hervé Quintens, Mélanie Guyot, Florence Dupré, Jérôme Durivault, Jean-François Roussel, Damien Ambrosetti, Gilles Pagès, Renaud Grépin, Aurore Dumond
Publikováno v:
Theranostics
Metastatic clear cell renal cell carcinomas (mRCC) over-express the vascular endothelial growth factor (VEGF). Hence, the anti-VEGF antibody bevacizumab/Avastin (BVZ) combined with interferon alpha (IFN) was approved for the treatment of mRCC. Howeve
Autor:
Riccardo Bellazzi, Giovanna Damia, Davide Ambrosetti, Giulia Gobbi, Valentina Sancisi, Francesca Reggiani, Silvia Strocchi, Elisabetta Sauta, Giacomo Santandrea, Massimiliano Paci, Federica Torricelli, Alessia Ciarrocchi, Elena Tagliavini, Eleonora Zanetti
Publikováno v:
Cancers, Vol 13, Iss 3477, p 3477 (2021)
Cancers
Volume 13
Issue 14
Cancers
Volume 13
Issue 14
Simple Summary The main histological subtypes of lung cancer are small-cell lung cancer (SCLC) and non-small-cell lung cancer (NSCLC). NSCLC is further subdivided into squamous-cell carcinoma (SCC) and adenocarcinoma (AD). Despite the recent introduc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa555452206e6c13f70445801330f359
https://hdl.handle.net/11585/858628
https://hdl.handle.net/11585/858628
Understanding the molecular mechanisms driving resistance to anti-cancer drugs is both a crucial step to define markers of response to therapy and a clinical need in many cancer settings. YAP and TAZ transcriptional cofactors behave as oncogenes in d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d81e5933a796debfcdb46c041d9907be
http://hdl.handle.net/11585/808196
http://hdl.handle.net/11585/808196
Autor:
Béatrice Cenciu, Bérengère Dadone-Montaudié, Ilaria Di Mauro, Vincent Bland, Myriam Decaussin-Petrucci, Damien Ambrosetti, Jonathan Derman, Pierre-Alexandre Just, Nathalie Rioux-Leclercq, Claire Arbaud, Florence Pedeutour, Vincent Molinié, F. Arbib, Mathilde Sibony
Publikováno v:
Genes, Chromosomes and Cancer
Genes, Chromosomes and Cancer, Wiley, 2021, 60 (11), pp.772-784. ⟨10.1002/gcc.22985⟩
Genes, Chromosomes & Cancer
Genes, Chromosomes & Cancer, 2021, 60 (11), pp.772-784. ⟨10.1002/gcc.22985⟩
Genes, Chromosomes and Cancer, Wiley, 2021, 60 (11), pp.772-784. ⟨10.1002/gcc.22985⟩
Genes, Chromosomes & Cancer
Genes, Chromosomes & Cancer, 2021, 60 (11), pp.772-784. ⟨10.1002/gcc.22985⟩
International audience; The accurate diagnosis of Xp11-translocation renal cell carcinoma (RCC) in adults is challenging. TFE3 (located on chromosome X) fuses with a partner gene generally located on another chromosome. In rare cases TFE3 may fuse wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51fdfbe9df42ed91380a691dd95c8857
https://hal.archives-ouvertes.fr/hal-03476898
https://hal.archives-ouvertes.fr/hal-03476898
Autor:
Maeva Dufies, Alexandre Bozec, Frederic Luciano, Julie Rousset, Olivia Rastoin, Esma Saada-Bouzid, Damien Ambrosetti, Isabelle Bourget, Anais Hagege, Christopher Montemagno, Julien Boyer, Julien Parola, Gilles Pagès, Yihai Cao, Xingkang He
Publikováno v:
SSRN Electronic Journal.
Local or metastatic relapses following surgery, radiotherapy and chemotherapy (cisplatin) are the leading causes of death of patients with head and neck squamous cell carcinoma (HNSCC). In the current study, we showed that acquired resistance to radi
Autor:
Gallo M., Guarnotta V., De Cicco F., Rubino M., Faggiano A., Colao A., Albertelli M., Altieri B., Ambrosetti E., Bianchi A., Bottiglieri L., Campione S., Carra S., Di Dato C., DiMolfetta S., Di Sarno A., Fanciulli G., Ferone D., Ferrau F., Giannetta E., Grillo F., Grossrubatscher E. M., Guadagno E., Isidori A., Lo Calzo F., Malandrino P., Martini C., Messina E., Modica R., Muscogiuri G., Pizza G., Razzore P., Rizza L., Ruggeri R. M., Sciammarella C., Vitale G., Zatelli M. C.
Purpose: Merkel cell carcinoma (MCC) is a rare, aggressive neuroendocrine carcinoma arising from the skin. We aimed to review and deal with some of the most relevant controversial topics on the correct use of immunotherapy for the treatment of MCC. M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb63929e872b8e986bf72f9645c0440f
http://hdl.handle.net/11573/1413703
http://hdl.handle.net/11573/1413703